1. Which one of the following statements about vaccine-preventable disease (VPD) is TRUE:
A. Progress has been made in decreasing VPD during the past 50 years
B. Some progress has been made in decreasing VPD in limited areas, between 2011 and 2012
C. There is more work to be done to reduce the deaths caused by VPD
D. All of the above
2. Pharmacists can play several roles in the immunization neighborhood, including which of the following:
A. Being an immunization advocate
B. Educating patients about vaccines
C. Partnering with others to provide vaccines
D. All of the above
3. All of the following are changes to the 2014 Adult Immunization Schedule, EXCEPT:
A. New Varicella recommendations
B. New Pneumococcal vaccine recommendations
C. Haemophilus influenzae type B (HiB) bar added to the chart
D. Additional influenza footnote added about recombinant influenza vaccine (RIV) and live-attenuated influenza vaccine (LAIV) for children 2 to 8 years of age
4. The National Vaccine Advisory Committee (NVAC) sets standards for adult immunizations. Which of the following are NVAC recommendations:
A. That only immunizing providers incorporate an immunization needs assessment into every clinical encounter
B. That nonimmunizing providers refer patients with immunization needs to other providers and that they follow up to ensure the patient received the immunization
C. That only immunizing providers understand how to access immunization information systems
D. That nonimmunizing providers place information about immunizing providers in their practice sites
5. With regard to immunizations,
A. Surveys completed by both physicians and patients show their perceptions of vaccination discussions during clinic visits are very aligned
B. Most adults are aware of their immunization needs across the majority of VPDs
C. Adults often access vaccinations at places that are open in the evening and on weekends and holidays
D. Tremendous progress has been made in reaching Healthy People 2020 immunization goals with few gaps remaining
6. Contraindications and precautions across most inactivated vaccines include all of the following, EXCEPT:
A. History of severe allergic reaction to any vaccine component
B. History of severe allergic reaction to gentamicin or gelatin
C. Moderate or severe illness, with or without fever
D. History of Guillain-Barré Syndrome within 6 weeks of previous vaccination
7. With regard to LAIVs, all of the following statements are TRUE, EXCEPT:
A. They should not be administered until 48 hours after antiviral therapy is discontinued
B. Advisory Committee on Immunization Practices (ACIP) recommends persons with asthma and other chronic conditions be given the inactivated influenza vaccine (IIV)
C. Adults aged ≥ 50 years should receive the IIV
D. Post-vaccine administration, antiviral therapy agents should not be administered for 7 days
8. A man, 65 years of age, with hypertension and no other chronic conditions, presents at the pharmacy and inquires about getting a pneumonia vaccine. He does not remember if he has received a pneumonia vaccine before. He wants to get immunized because he has relatives who have recently contracted pneumonia and were very sick. He hopes to avoid the same situation. What vaccine would be appropriate for this patient?
A. PCV13 only
B. PPSV23 only
C. PCV13 followed by PPSV23 6-12 months later
D. PPSV23 followed by PCV13 one or more years later
9. What statement regarding Florida pharmacists' immunization authority is FALSE:
A. The first law allowing pharmacists to provide influenza immunizations was passed in 2007
B. Pharmacists were given authority to provide pneumococcal and zoster vaccinations in 2012
C. Pharmacists were given authority to provide meningococcal vaccinations in 2014
D. Pharmacists may only provide the zoster vaccine via a specific patient prescription
10. The Pharmacist Immunization Services Standard Training Program includes all of the following, EXCEPT:
A. Proof of 30 hours of annual CE about immunization issues after initially completing the program
B. Education about vaccine mechanism of action, contraindications, drug interactions, and monitoring after vaccine administration
C. How to report adverse reactions to the Vaccine Adverse Event Reporting Program (VAERS)
D. Education about immunization schedules, screening questions, informed consent, and state registry reporting requirements